Annual FCF
-$85.39 M
+$37.53 M+30.53%
December 31, 2023
Summary
- As of February 12, 2025, AVIR annual free cash flow is -$85.39 million, with the most recent change of +$37.53 million (+30.53%) on December 31, 2023.
- During the last 3 years, AVIR annual FCF has fallen by -$382.10 million (-128.78%).
- AVIR annual FCF is now -128.78% below its all-time high of $296.71 million, reached on December 31, 2020.
Performance
AVIR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$23.04 M
+$19.17 M+45.42%
September 30, 2024
Summary
- As of February 12, 2025, AVIR quarterly free cash flow is -$23.04 million, with the most recent change of +$19.17 million (+45.42%) on September 30, 2024.
- Over the past year, AVIR quarterly FCF has dropped by -$5.44 million (-30.95%).
- AVIR quarterly FCF is now -107.23% below its all-time high of $318.52 million, reached on December 31, 2020.
Performance
AVIR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$126.94 M
-$5.44 M-4.48%
September 30, 2024
Summary
- As of February 12, 2025, AVIR TTM free cash flow is -$126.94 million, with the most recent change of -$5.44 million (-4.48%) on September 30, 2024.
- Over the past year, AVIR TTM FCF has dropped by -$41.83 million (-49.15%).
- AVIR TTM FCF is now -141.36% below its all-time high of $306.93 million, reached on September 30, 2021.
Performance
AVIR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
AVIR Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +30.5% | -30.9% | -49.1% |
| 3 y3 years | -128.8% | -30.9% | -49.1% |
| 5 y5 years | -978.2% | -30.9% | -49.1% |
AVIR Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +30.5% | -42.9% | +69.5% | -49.1% | +28.2% |
| 5 y | 5-year | -128.8% | +30.5% | -107.2% | +69.5% | -141.4% | +28.2% |
| alltime | all time | -128.8% | +30.5% | -107.2% | +69.5% | -141.4% | +28.2% |
Atea Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$23.04 M(-45.4%) | -$126.94 M(+4.5%) |
| Jun 2024 | - | -$42.20 M(+5.9%) | -$121.49 M(+27.3%) |
| Mar 2024 | - | -$39.87 M(+82.6%) | -$95.41 M(+11.7%) |
| Dec 2023 | -$85.39 M(-30.5%) | -$21.83 M(+24.1%) | -$85.39 M(+0.3%) |
| Sep 2023 | - | -$17.59 M(+9.1%) | -$85.11 M(-4.1%) |
| Jun 2023 | - | -$16.12 M(-46.0%) | -$88.78 M(-5.3%) |
| Mar 2023 | - | -$29.85 M(+38.5%) | -$93.72 M(-23.8%) |
| Dec 2022 | -$122.92 M | -$21.55 M(+1.3%) | -$122.92 M(-30.5%) |
| Sep 2022 | - | -$21.26 M(+0.9%) | -$176.80 M(+33.0%) |
| Jun 2022 | - | -$21.07 M(-64.3%) | -$132.94 M(+2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$59.05 M(-21.7%) | -$129.22 M(+48.5%) |
| Dec 2021 | -$87.01 M(-129.3%) | -$75.42 M(-433.7%) | -$87.00 M(-128.3%) |
| Sep 2021 | - | $22.60 M(-230.3%) | $306.93 M(+11.7%) |
| Jun 2021 | - | -$17.35 M(+3.0%) | $274.83 M(-3.4%) |
| Mar 2021 | - | -$16.84 M(-105.3%) | $284.38 M(-4.2%) |
| Dec 2020 | $296.71 M(-2412.4%) | $318.52 M(-3454.2%) | $296.71 M(-1460.5%) |
| Sep 2020 | - | -$9.50 M(+21.7%) | -$21.81 M(+77.1%) |
| Jun 2020 | - | -$7.80 M(+73.1%) | -$12.31 M(+173.1%) |
| Mar 2020 | - | -$4.51 M | -$4.51 M |
| Dec 2019 | -$12.83 M(+62.0%) | - | - |
| Dec 2018 | -$7.92 M | - | - |
FAQ
- What is Atea Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals annual FCF year-on-year change?
- What is Atea Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals quarterly FCF year-on-year change?
- What is Atea Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals TTM FCF year-on-year change?
What is Atea Pharmaceuticals annual free cash flow?
The current annual FCF of AVIR is -$85.39 M
What is the all time high annual FCF for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high annual free cash flow is $296.71 M
What is Atea Pharmaceuticals annual FCF year-on-year change?
Over the past year, AVIR annual free cash flow has changed by +$37.53 M (+30.53%)
What is Atea Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of AVIR is -$23.04 M
What is the all time high quarterly FCF for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high quarterly free cash flow is $318.52 M
What is Atea Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, AVIR quarterly free cash flow has changed by -$5.44 M (-30.95%)
What is Atea Pharmaceuticals TTM free cash flow?
The current TTM FCF of AVIR is -$126.94 M
What is the all time high TTM FCF for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high TTM free cash flow is $306.93 M
What is Atea Pharmaceuticals TTM FCF year-on-year change?
Over the past year, AVIR TTM free cash flow has changed by -$41.83 M (-49.15%)